Documento de Consenso sobre pneumonia nosocomial1,2

Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimi-crobial therapy, and preventive strategies. A consensus statement, American Thoracic Society.

Am J Respir Crit Care Med, 153 (1996), pp. 1711-1725

http://dx.doi.org/10.1164/ajrccm.153.5.8630626 | Medline

[4.]

J. Rello, J.A. Paiva, J. Baraibar, F. Barcenilla, M. Bodi, D. Castander, H. Correa, E. Diaz, J. Garnacho, M. Llorio, M. Rios, A. Rodriguez.

Solé-Violan.

International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia. Chest, 120 (2001), pp. 955-970

Medline

[5.]

R. Jordà, A. Torres, F.J. Ariza, F. Álvarez-Lerma, F. Barcenilla, et al.

Recomendaciones para el tratamiento de la pneumonia intrahospitalaria grave.

Arch Bronconeumol, 40 (2004), pp. 518-533

Medline

[6.]

J. Chastre, J.Y. Fagon.

Ventilator-associated pneumonia.

Am J Respir Crit Care Med, 165 (2002), pp. 867-903

http://dx.doi.org/10.1164/ajrccm.165.7.2105078 | Medline

[7.]

A. Torres, R. Aznar, J.M. Gatell, et al.

Incidence, risk, and prognosis factores of nosocomial pneumonia in mechanically ventilated patients.

Am Rev Respir Dis, 142 (1990), pp. 523-528

http://dx.doi.org/10.1164/ajrccm/142.3.523 | Medline

[8.]

J. Rello, D.A. Ollendorf, G. Oster, V. Montserrat, L. Bellm, R. Redman, M.R. Kollef.

Epidemiology and outcomes of ventilator-associated pneumonia in a large US data-base.

Chest, 122 (2002), pp. 2115-2121

Medline

[9.]

D.K. Heyland, D.J. Cook, L. Griffith, et al.

The attributa-ble morbidity and mortality of ventilator-associated pneumonia in the critical ill patient.

Am J Respir Crit Care Med, 159 (1999), pp. 1249-1256

http://dx.doi.org/10.1164/ajrccm.159.4.9807050 | Medline

[10.]

A.A. El Solh, P. Sikka, F. Ramadan, J. Davies.

Etiology of severe pneumonia in the very elderly.

Am J Respir Crit Care Med, 163 (2001), pp. 645-651

http://dx.doi.org/10.1164/ajrccm.163.3.2005075 | Medline

[11.]

A.A. El Solh, A.T. Aquilina, R.S. Dhillon, F. Ramadan, P. Nowak, J. Davies.

Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia.

Am J Respir Crit Care Med, 166 (2002), pp. 1038-1043

http://dx.doi.org/10.1164/rccm.200202-123OC | Medline

[12.]

N. Fabregas, S. Ewig, A. Torres, et al.

Clinical diagnosis of ventilator associated pneumonia revisited: comparative evaluation usind immediate post moprtem biopsies.

Thorax, 54 (1999), pp. 867-873

Medline

[13.]

C. Delclaux, E. Roupie, F. Blot, L. Brochard, F. Lemaire, C. Brun-Buisson.

Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis.

Am J Respir Crit Care Med., 156 (1997), pp. 1092-1098

http://dx.doi.org/10.1164/ajrccm.156.4.9701065 | Medline

[14.]

C.M. Luna, P. Vujacich, M.S. Niederman, C. Vay, C. Ghe-rardi, J. Matera, E.C. Jolly.

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.

Chest, 111 (1997), pp. 676-685

Medline

[15.]

M. Iregui, S. Ward, G. Sherman, V.J. Fraser, M.H. Kollef.

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneu-monia.

Chest, 122 (2002), pp. 262-268

Medline

[16.]

F. Alvarez-Lerma.

Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group.

Intensive Care Med, 22 (1996), pp. 387-394

Medline

[17.]

J.Y. Fagon, J. Chastre, M. Wolff, C. Gervais, S. Parer-Aubas, F. Stephan, T. Similowski, A. Mercat, J.L. Diehl, J.P. Sollet, A. Tenaillon.

Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial.

Ann Intern Med, 132 (2000), pp. 621-630

Medline

[18.]

J. Chastre, M. Wolff, J.Y. Fagon, S. Chevret, F. Thomas, D. Wermert, E. Clementi, J. Gonzalez, D. Jusserand, P. Asfar, D. Perrin, F. Fieux, S. Aubas.

PneumA Trial Group: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

JAMA., 290 (2003), pp. 2588-2598

http://dx.doi.org/10.1001/jama.290.19.2588 | Medline

[19.]

D.K. Heyland, D.J. Cook, J. Marshall, M. Heule, B. Guslits, J. Lang, R. Jaeschke.

The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Canadian Critical Care Trials Group.

Chest, 115 (1999), pp. 1076-1084

Medline

[20.]

S.H. Kirtland, D.E. Corley, R.H. Winterbauer, S.C. Spring-meyer, K.R. Casey, N.B. Hampson, D.F. Dreis.

The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria.

Chest, 112 (1997), pp. 445-457

Medline

[21.]

D. Wermert, C.H. Marquette, M.C. Copin, F. Wallet, A. Fraticelli, P. Ramon, A.B. Tonnel.

Influence of pulmonary bacteriology and histology on the yield of diagnostic procedures in ventilator-acquired pneumonia.

Am J Respir Crit Care Med, 158 (1998), pp. 139-147

http://dx.doi.org/10.1164/ajrccm.158.1.9710061 | Medline

[22.]

J.J. Rouby, E. Martin De Lassale, P. Poete, M.H. Nicolas, L. Bodin, V. Jarlier, Y. Le Charpentier, J. Grosset, P. Viars.

Noso-comial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects.

Am Rev Respir Dis, 146 (1992), pp. 1059-1066

http://dx.doi.org/10.1164/ajrccm/146.4.1059 | Medline

[23.]

J. Pugin, R. Auckenthaler, N. Mili, et al.

Diagnosis of ventilator-associated pneumonia by bacteriologic analy- sis of bronchoscopic and non-bronchoscopic “blind” bronchoalveolar lavage fluid.

Am Rev Respir Dis, 143 (1991), pp. 1121-1129

http://dx.doi.org/10.1164/ajrccm/143.5_Pt_1.1121 | Medline

[24.]

N. Singh, P. Rogers, C.W. Atwood, et al.

Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription.

Am J Respir Crit Care Med, 162 (2000), pp. 505-511

http://dx.doi.org/10.1164/ajrccm.162.2.9909095 | Medline

[25.]

C.M. Luna, D. Blanzaco, M.S. Niederman, et al.

Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome.

Crit Care Med, 31 (2003), pp. 676-682

http://dx.doi.org/10.1097/01.CCM.0000055380.86458.1E | Medline

[26.]

M. Fartoukh, B. Maître, S. Honoré, et al.

Diagnosing pneumonia during mechanical ventilation. The Clinical Pulmonary Infection Score Revisited.

Am J Respir Crit Care Med, 168 (2003), pp. 173-179

http://dx.doi.org/10.1164/rccm.200212-1449OC | Medline

[27.]

L. Papazian, P. Thomas, L. Garbe, et al.

Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia.

Am J Resp Crit Care Med, 152 (1995), pp. 1982-1991

http://dx.doi.org/10.1164/ajrccm.152.6.8520766 | Medline

[28.]

C. Franklin, et al.

Reduced mortality of pneumococcal bacteremia after early intensive care.

J Intensive Care, 6 (1994), pp. 302-307

[29.]

M. Niederman.

Gram-negative colonization of the respiratory tract: pathogenesis and clinical consequences.

Semin Respir Infect, 5 (1990 Sep), pp. 173-184

Medline

[30.]

J. Hayon, C. Figliolini, A. Combes, J.L. Trouillet, N. Kassis, M.C. Dombret, C. Gibert, J. Chastre.

Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia.

Am J Respir Crit Care Med, 165 (2002), pp. 41-46

http://dx.doi.org/10.1164/ajrccm.165.1.2105077 | Medline

[31.]

E.R.S. Task.

Force. Ventilator-associated pneumonia.

Eur Respir J, 17 (2001), pp. 1034-1045

Medline

[32.]

C. Luna, A. Videla, J. Mattera, et al.

Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia.

Chest, 116 (1999), pp. 1075-1084

Medline

[33.]

O.C. Tablan, et al.

Guidelines for preventing health-care-associated pneumonia: recomendations of the CDC and the Health-care Infection Control Practices Advisory Committee.

MMWR Recomm Rep, 53 (2004), pp. 10-13

[34.]

M.H. Kollef, G. Sherman, S. Ward, et al.

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Chest, 115 (1999), pp. 462-474

Medline

[35.]

M. Kollef, S. Ward.

The Influence of Mini-BAL Cultures on Patient Outcomes, Implications for the Antibiotic Management of Ventilator-Associated Pneumonia.

Chest, 113 (1998), pp. 412-420

Medline

[36.]

M. Weinstein, M. Towns, S. Quartey, et al.

The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Micro-biology, Epidemiology, and Outcome of Bacteremia and Fungemia in Adults.

CID, 24 (1997), pp. 584-602

[37.]

P.D. Paepe, F.M. Belpaire, W.A. Buylaert.

Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.

Clin Pharma-cokinet, 41 (2002), pp. 1135-1151

[38.]

J.G. Pereira.

Antibioterapia na pneumonia: A emer-gência das resistências.

Revista de Infecções Respiratórias, 1 (2005), pp. 4-12

[39.]

E.H. Ibrahim, S. Ward, G. Sherman, R. Schaiff, V.J. Fraser, M.H. Kollef.

Experience with a clinical guideline for the treatment of ventilator associated pneumonia.

Crit Care Med, 29 (2001), pp. 1109-1115

Medline

[40.]

B. Sieger, S.J. Berman, R. Geckler, S. Farkas.

Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with to-bramycin: A randomized study.

Crit Care Med, 25 (1997), pp. 1663-1670

Medline

[41.]

J. Rello, L. Vidaur, A. Sandiumenge, et al.

De-escalation therapy in ventilator-associated pneumonia.

Crit Care Med, 32 (2004), pp. 2183-2190

Medline

[42.]

S.T. Micek, S. Ward, V.J. Fraser, M.H. Kollef.

A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneu-monia.

Chest, 125 (2004), pp. 1791-1799

Medline

[43.]

M.R. Jacobs.

Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters.

Clin Microbiol Infect, 7 (2001), pp. 589-596

Medline

[44.]

D. Andes, J. Anon, M.R. Jacobs, W.A. Craig.

Application of pharmacokinetics and pharmacodynamics to antimi-crobial therapy of respiratory tract infections.

Clin Lab Med, 24 (2004), pp. 477-502

http://dx.doi.org/10.1016/j.cll.2004.03.009 | Medline

[45.]

W.A. Craig.

Basic pharmacodynamics of antibacterials with clinical applications to the use of b-lactams, glycopeptides, and linezolid.

Infect Dis Clin N Am, 17 (2003), pp. 479-501

[46.]

C.M. Isada, B.L. Kasten, M.P. Goldman, L.D. Gray, J.A. Aberg.

Infectious diseases handbook, 5th edition,

[47.]

J.G. Pereira.

Antibióticos em perfusão contínua.

Revista Portuguesa de Medicina Intensiva, 13 (2004), pp. 15-19

[48.]

K. Leder, J.D. Turnidge, T.M. Korman, M.L. Grayson.

The clinical efficacy of continuous-infusion flucloxacil-lin in serious staphylococcal sepsis.

Journal of Antimi-crobial Chemotherapy, 43 (1999), pp. 113-118

[49.]

E.M. Grant, J.L. Kuti, D.P. Nicolau, C. Nightingale, R. Quin-tiliani.

Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital.

Pharmacotherapy, 22 (2002), pp. 471-483

Medline

[50.]

J. Lipmana, C.D. Gomersallb, T. Ginc, G.M. Joyntb, R.J. Youngb.

Continuous infusion ceftazidime in intensive care: a randomized controlled trial.

J Antimicrobial Chemotherapy, 43 (1999), pp. 309-311

[51.]

G.M. Joynt, J. Lipman, C.D. Gomersall, R.J. Young, E.L.Y. Wong, T. Gin.

The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.

J Antimicrobial Chemotherapy, 47 (2001), pp. 421-429

[52.]

J. Lipman, S.C. Wallis, C. Rickard.

Low plasma cefepime levels in critically ill septic patients: Pharmacokinetic modeling indicates improved troughs with revised dosing.

Antimicrob Agent Chemother, 43 (1999), pp. 2559-2561

[53.]

J. Li, R. Nation, J. Turnidge, R. Milne, et al.

Colistin: the reemerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

Lancet Infect Dis, 6 (2006), pp. 589-601

http://dx.doi.org/10.1016/S1473-3099(06)70580-1 | Medline

[54.]

J. Turnidge.

Pharmacodynamics and dosing of ami-noglycosides.

Infect Dis Clin N Am, 17 (2003), pp. 503-528

[55.]

E.D. Hermsen, C.J. Sullivan, J.C. Rotschafer.

Polymyxins: Pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications.

Infect Dis Clin N Am, 17 (2003), pp. 54562

[56.]

J. Li, J. Turnidge, R. Milne, R.L. Nation, K. Coulthard.

In vitro pharmacodynamic properties of Colistin and Colistin Methanesulfonate against Pseudomonas aeruginosa iso-lates from patients with cystic fibrosis.

Antimicrob Agent Chemother, 45 (2001), pp. 781-785

[57.]

D.L. Wyncoll, R. Bowry, L.J. Giles.

Antibiotics in continuous infusion: Time for re-evaluation?.

Year Book of Intensive Care and Emergency Medicine, pp. 398-406

[58.]

J. Rello, V. Ausina, et al.

Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.

Chest, 104 (1993), pp. 1230-1235

Medline

[59.]

J.L. Trouillet, J. Chastre, A. Vuagnat, et al.

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

Am J Respir Crit Care Med, 157 (1998), pp. 531-539

http://dx.doi.org/10.1164/ajrccm.157.2.9705064 | Medline

[60.]

J.Y. Fagon, J. Chastre, Y. Domart, et al.

Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques.

Am Rev Respir Dis, 139 (1989), pp. 877-884

http://dx.doi.org/10.1164/ajrccm/139.4.877 | Medline

[61.]

J. Rello, E. Quintana, V. Ausina, et al.

Incidence, etiology and outcome of nosocomial pneumonia in mechanically ventilated patients.

Chest, 100 (1991), pp. 439-444

Medline

[62.]

S.C. Brewer, R.G. Wunderink, C.B. Jones, et al.

Ventila-tor-associated pneumonia due to Pseudomonas aeruginosa.

Chest, 109 (1996), pp. 1019-1029

Medline

[63.]

O. Leroy, S. Jaffré, T. d’Ecrivan, et al.

Hospital-Acquired Pneumonia. Risk factors for antimicrobial-resistant causative pathogens in critically ill patients.

Chest, 123 (2003), pp. 2034-2042

Medline

[64.]

R.T. Sadikot, T.S. Blackwell, J.W. Christman, et al.

Pathogen-host interaction in Pseudominas aeruginosa Pneumonia.

Am J Respir Crit Care Med., 171 (2005), pp. 1209-1223

http://dx.doi.org/10.1164/rccm.200408-1044SO | Medline

[65.]

I. Chatzinikoloau, D. Abi-Said, G.P. Bodey, et al.

Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 24 episodes.

Arch Intern Med, 160 (2000), pp. 501-509

Medline

[66.]

J. Chastre, J.L. Trouillet.

Problem pathogens Pseudomonas aeruginosa and Acinetobacter.

Semin Respire Infect, 15 (2000), pp. 287-298

[67.]

F. Vidal, J. Mens, J.A. Martinez, et al.

Pseudomonas aeruginosa bacteremia in patients infected with HIV-1.

Eur J Clin Microbiol Infect Dis, 18 (1999), pp. 473-477

Medline

[68.]

J. Rello, V. Ausina, M. Ricart, et al.

Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia.

Intensive Care Med, 20 (1994), pp. 193-198

Medline

[69.]

N. Sopena, M. Sabria, M.L. Pedro-Botet, et al.

Prospective study of community-acquired pneumonia of bacterial etiology in adults.

Eur J Clin Microbiol Infect Dis, 18 (1999), pp. 852-858

Medline

[70.]

F. Aranciba, T.T. Bauer, S. Ewig, et al.

Community-acquired pneumonia due to gram-negative bacteria and Pseu-domonas aeruginosa.

Arch Intern Med, 162 (2002), pp. 1849-1858

Medline

[71.]

K.H. Groenewegen, et al.

Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study.

Respir Med, 97 (2003), pp. 770-777

Medline

[72.]

S. Nseir, C. Pompeo, S. Soubrier, et al.

Impact of Ventilator-associated pneumonia on outcome in patients with COPD.

Chest, 128 (2005), pp. 1650-1656

http://dx.doi.org/10.1378/chest.128.3.1650 | Medline

[73.]

E.H. Ibrahim, S. Ward, G. Sherman, et al.

A comparative analysis of patients with early-onset versus late-onset nosoco-mial pneumonia in the ICU setting.

Chest, 117 (2000), pp. 1434-1442

Medline

[74.]

J. Rello, M. Sa-Borges, H. Correa, S.R. Leal, J. Baraibar.

Variations in etiology of ventilator-associated pneumo-nia across four treatment sites: implications for antimi-crobial prescribing practices.

Am J Respir Crit Care Med, 160 (1999), pp. 608-613

http://dx.doi.org/10.1164/ajrccm.160.2.9812034 | Medline

[75.]

E.H. Ibrahim, G. Sherman, S. Ward, et al.

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.

Chest, 118 (2000), pp. 146-155

Medline

[76.]

J. Rello, A. Torres, M. Ricart, et al.

Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes.

Am J Respir Crit Care Med, 150 (1994), pp. 1545-1549

http://dx.doi.org/10.1164/ajrccm.150.6.7952612 | Medline

[77.]

J. Rello, E. Quintana, V. Ausina, et al.

Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients.

Am Rev Respir Dis, 142 (1990), pp. 1320-1324

http://dx.doi.org/10.1164/ajrccm/142.6_Pt_1.1320 | Medline

[78.]

J.S. Solomkin, H.S. Bjornson, M. Cainzos, et al.

A consensus statement on empiric therapy for suspected gram-positive infections in surgical patients.

Am J Surgery, 187 (2004), pp. 134-145

[79.]

A. Vuagnat, R. Stern, A. Lotthe, et al.

High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion.

Journal Clinical Pharmacy Therapeutics, 29 (2004), pp. 351-357

[80.]

J.M. Pereira, A. Azevedo, J.A. Paiva.

Continuous infusion of vancomycin: is it a step forward in vancomycin therapy?.

Intensive Care Med, 31 (2005), pp. S222

[81.]

M. Wysocki, F. Delatour, F. Faurisson, A. Rauss, et al.

Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study.

Antimicrob Agents Chemother, 45 (2001), pp. 2460-2467

Medline

[82.]

J. Rello, J. Sole-Violan, M. Sa-Borges, J. Garnacho-Montero, et al.

Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides.

Crit Care Med, 33 (2005), pp. 1983-1987

Medline

[83.]

J. Garnacho-Montero, C. Ortiz-Leyva, F.J. Jiménez-Jimé-nez, et al.

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: A comparision with imipenem-sus-ceptible VAP.

Clin Infect Dis, 36 (2003), pp. 1111-1118

http://dx.doi.org/10.1086/374337 | Medline

[84.]

J. Baraibar, H. Correa, D. Mariscal, et al.

Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia.

Chest, 112 (1997), pp. 1050-1054

Medline

[85.]

S. Mahgoub, et al.

Underlying characteristics of patients harbouring higly resistant Acinetobacter baumannii.

Am J Infect Control, 30 (2002), pp. 386-390

Medline

[86.]

Rodriguez-Baño, et al.

Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals.

Infect Control Hosp Epidemiol, (2004), pp. 825-831

[87.]

M. Ayan, et al.

Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter infection in a teaching hospital.

J Infect, 54 (2003), pp. 39-45

[88.]

D. Villers, E. Espaze, M. Coste-Burel, et al.

Nosoco-mial Acinetobacter baumannii infections: microbiological and clinical epidemiology.

Ann Intern Med, 129 (1998), pp. 182-189

Medline

[89.]

X. Corbella, M. Pujol, J. Ayats, et al.

Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter bau-mannii.

Clin Infect Dis, 23 (1996), pp. 329-334

Medline

[90.]

O. Lortholary, J.-Y. Fagon, A.B. Hoi, et al.

Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis.

Clin Infect Dis, 20 (1995), pp. 790-796

Medline

[91.]

O.C. Tablan, et al.

Guidelines for preventing health-care-associated pneumonia: recomendations of the CDC and the Health-care Infection Control Practices Advisory Committee.

MMWR Recomm Rep, 53 (2004), pp. 1-36

Medline

[92.]

M. Ebiary, X. Sarmiento, A. Torres, S. Nogue, E. Mesalles, M. Bodi, J. Almirall.

Prognostic factors of severe Legionella pneumonia requiring admission to ICU.

Am J Respir Crit Care Med, 156 (1997), pp. 1467-1472

http://dx.doi.org/10.1164/ajrccm.156.5.97-04039 | Medline

[93.]

Ls Tkatch, S. Kusne, I. WD, et al.

Epidemiology of legionella pneumonia and factors associated with legio-nella-related mortality at a terciary care center.

Clin Infect Dis, 27 (1998), pp. 1479-1486

Medline

[94.]

J. Carratala, F. Gudiol, R. Pallares, et al.

Risk factors for nosocomial Legionella pneumophila pneumonia.

Am J Respir Crit Care Med, 149 (1994), pp. 625-629

http://dx.doi.org/10.1164/ajrccm.149.3.8118629 | Medline

[95.]

N.M. Le Saux, L. Sekla, J. McLeod, S. Parker, D. Rush, J.R. Jeffery, R.C. Brunham.

Epidemic of nosocomial Legionnai-res’ disease in renal transplant recipients: a case-control and environmental study.

Can Med Assoc J, 140 (1989), pp. 1047-1053

[96.]

V.L. Yu, et al.

Legionnaires disease: new clinical perspective from a prospective pneumonia study.

Am J Med, 73 (1982), pp. 357-361

Medline

[97.]

J. Stout, V.L. Yu, R.M. Vickers, J. Shonnard.

Potable water supply as the hospital reservoir for Pittsburgh pneu-monia agent.

Lancet, 1 (1982), pp. 471-472

http://dx.doi.org/10.1016/S2213-2600(13)70120-6 | Medline

[98.]

M. Sabria, M. Campins.

Legionnaire’disease: update on epidemiology and management options.

Am J Respir Med, 2 (2003), pp. 235-243

Medline

[99.]

G.A. Ortolano, M.B. Mc Alister, J.A. Angelbeck, et al.

Hospital water point-of-use filtration: A complementary strategy to reduce the risk of nosocomial infection.

Am J Infect Control, 33 (2005), pp. S1-S19

http://dx.doi.org/10.1016/j.ajic.2005.03.014 | Medline

[100.]

R.A. Venezia, M.D. Agresta, E.M. Hanley, K. Urquhart, D. Schoonmaker.

Nosocomial legionellosis associated with aspiration of nasogastric feedings diluted in tap water.

Infect Control Hosp Epidemiol, 15 (1994), pp. 529-533

Medline

[101.]

J. Darelid, S. Lofgren, B.E. Malmvall.

Control of nosocomial Legionnaires’ disease by keeping the circulating hot water temperature above 55 degrees C: experience from a 10-year surveillance programme in a district general hospital.

J Hosp Infect, 50 (2002), pp. 213-219

http://dx.doi.org/10.1053/jhin.2002.1185 | Medline

[102.]

M. Hilf, V.L. Yu, J. Sharp, et al.

Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients.

Am J Med, 87 (1989), pp. 540-546

Medline

[103.]

J.A. Korvick, C.S. Bryan, B. Farber, et al.

Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy.

Antimicrob Agents Chemother, 36 (1992), pp. 2639-2644

Medline

[104.]

A. Sandiumengue, E. Diaz, M. Bodi, J. Rello.

Therapy of ventilator-associated pneumonia- A patient-based approach based on the ten rules of “The Tarragona Strategy”.

Intensive Care Med., 29 (2003), pp. 876-883

http://dx.doi.org/10.1007/s00134-003-1715-1 | Medline

[105.]

R.G. Wunderink, J. Rello, S.K. Cammarata, R.V. Croos-Da-brera, M. Kollef.

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant staphylococcus aureus nosocomial pneumonia.

Chest, 124 (2003), pp. 1789-1797

Medline

[106.]

C.M. Lee, H.K. Lin, C.P. Liu, et al.

Treatment of pan-drug resistant Acinetobacter baumannii.

Scand J Infect Dis, 37 (2005), pp. 195-199

http://dx.doi.org/10.1080/00365540510026869 | Medline

[107.]

P.K. Linden, D.L. Paterson.

Parenteral and inhaled colistin fortreatment of ventilator-associated pneumonia.

Clin Infect Dis, 43 (2006), pp. S89-S94

http://dx.doi.org/10.1086/504485 | Medline

[108.]

A. Montero, Ariza, X. Corballa, et al.

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

J Antimicrob Chemother, 54 (2004), pp. 1085-1091

http://dx.doi.org/10.1093/jac/dkh485 | Medline

[109.]

J.M. Cisneros-Herreros, J. Garnacho-Montero, M.E. Pachon-Ibanez.

nosocomial pneumonia due to Acinetobacter bau-mannii.

Enferm Infecc Microbiol Clin, 23 (2005), pp. 46-51

Medline

[110.]

A. Michalopoulos, S.K. Kasiakou, Z. Mastora, et al.

Colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

Crit Care, 9 (2005), pp. R53-R59

http://dx.doi.org/10.1186/cc3020 | Medline

[111.]

J.J. Rahal.

Novel antibiotic combinations against infections with almost completely resistant Pseudomonas ae-ruginosa and Acinetobacter Species.

Clin Infect Dis, 43 (2006), pp. S95-S99

http://dx.doi.org/10.1086/504486 | Medline

[112.]

M.E. Falagas, S.K. Kasiakou, S. Tsiodras, et al.

The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.

Clin Med Res, 4 (2006), pp. 138-146

Medline

[113.]

M.L. Pedro-Botet, V. Yu.

Tratment and prevention of Legionella infection, (2006),

http://patients.uptodate.com/print.asp?print=true&file=pulm_inf/6738

[114.]

E.N. Vergis, A. Indorf, T. File, et al.

Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.

Arch Intern Med, 160 (2000), pp. 1294-1300

Medline

[115.]

R.M. Blazquez Garrido, F.J. Espinosa Parra, L. Frances, et al.

Antimicrobial chemotherapy for legionnaires disease: levofloxacin versus macrolides.

Clin Infect Dis, 40 (2005), pp. 800-806

http://dx.doi.org/10.1086/428049 | Medline

[116.]

D. Gruson, G. Hilbert, F. Vargas, R. Valentino, C. Bebear, A. Allery, C. Bebear, G. Gbikpi-Benissan, J.P. Cardinaud.

Rotation and restricted use of antibiotics in a medical intensive care unit: impact on the incidence of ventilator-associated pneumonia caused by antibiotic resistant gram-negative bacteria.

Am J Respir Crit Care Med, 162 (2000), pp. 837-843

http://dx.doi.org/10.1164/ajrccm.162.3.9905050 | Medline

[117.]

M. Ferrer, M. Ioanas, A. Torres.

Evaluation of non-responding patients with ventilator-associated pneumonia.

Yearbook of Intensive Care and Emergency Medicine, pp. 365-375

[118.]

S. Lowenkron, A. Fein.

The 10 most common questions about non-resolving pneumonia.

Clin Pulm Med, 2 (1995), pp. 8897

[119.]

T. Kuru, J.P. Lynch 3rd..

Nonresolving or slowly resolving pneumonia.

Clin Chest Med, 20 (1999), pp. 623-651

Medline

[120.]

L. Rome, G. Murali, M. Lippmann.

Nonresolving pneumonia and mimics of pneumonia.

Med Clin North Am, 85 (2001), pp. 1511-1530

Medline

[121.]

J. Rello, D. Mariscal, F. March, et al.

Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection?.

Am J Respir Crit Care Med, 157 (1998), pp. 912-916

http://dx.doi.org/10.1164/ajrccm.157.3.9703014 | Medline

[122.]

D.R. Silver, I.L. Cohen, P.F. Weinberg.

Recurrent Pseu-domonas aeruginosa pneumonia in an intensive care unit.

Chest, 101 (1992), pp. 194-198

Medline

[123.]

S. Crouch Brewer, R.G. Wunderink, C.B. Jones, et al.

Ventilator-associated pneumonia due to Pseudomonas ae-ruginosa.

Chest, 109 (1996), pp. 1019-1029

Medline

[124.]

S. Rowe, W.G. Cheadle.

Complications of nosoco-mial pneumonia in the surgical patient.

Am J Surg, 179 (2000), pp. 63-68

Medline

[125.]

D. Craven.

Preventing ventilator –associated pneumonia in adults.

Chest, 130 (2006), pp. 251-260

http://dx.doi.org/10.1378/chest.130.1.251 | Medline

[126.]

D.M. Berwick, D.R. Calkins, McCamnon, et al.

The 100.000 Lives Campaign: setting a goal and a deadline for improving health care quality.

JAMA, 295 (2006), pp. 324-327

http://dx.doi.org/10.1001/jama.295.3.324 | Medline

[127.]

G. van den Berghe, P. Wouters, F. Weekers, et al.

Intensive insulin therapy in critically ill patients.

N Engl J Med, 345 (2001), pp. 1359-1367

http://dx.doi.org/10.1056/NEJMoa011300 | Medline

1

Sociedade Portuguesa de Pneumologia e Sociedade Portuguesa de Cuidados Intensivos / Portuguese Society of Pulmonology and Intensive Care Society

2

O presente documento é simultaneamente publicado na Revista Portuguesa de Medicina Intensiva (2007; 14(1):7-30) / This work is published simultaneously in the Portuguese Journal of Intensive Care Medicine (2007; 14(1):7-30)

Indexed in:

Follow us:

Indexed in:

Follow us:

Subscribe to our newsletter